Plus Therapeutics Provides US Launch Update for its CNSide Diagnostic
July 31, 2025
CNSide available for the state of Texas in August 2025 Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for